Agilent Technologies, Inc. (NYSE:A) Shares Bought by Sumitomo Life Insurance Co.

Sumitomo Life Insurance Co. lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 2.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,351 shares of the medical research company’s stock after acquiring an additional 171 shares during the period. Sumitomo Life Insurance Co.’s holdings in Agilent Technologies were worth $943,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Crewe Advisors LLC lifted its holdings in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after acquiring an additional 101 shares during the last quarter. Ridgewood Investments LLC acquired a new stake in shares of Agilent Technologies during the 2nd quarter worth approximately $29,000. Rise Advisors LLC lifted its holdings in shares of Agilent Technologies by 527.8% in the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after purchasing an additional 190 shares during the last quarter. Riverview Trust Co acquired a new position in Agilent Technologies during the 1st quarter valued at approximately $41,000. Finally, Larson Financial Group LLC grew its stake in Agilent Technologies by 29,300.0% during the 1st quarter. Larson Financial Group LLC now owns 294 shares of the medical research company’s stock worth $43,000 after buying an additional 293 shares during the last quarter. 87.42% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on A. UBS Group boosted their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Barclays boosted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research note on Tuesday. Stifel Nicolaus restated a “buy” rating and issued a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. Bank of America increased their price objective on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Finally, Wolfe Research downgraded Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $144.36.

Agilent Technologies Stock Performance

Shares of A opened at $139.10 on Thursday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The firm’s 50 day moving average is $140.97 and its 200-day moving average is $138.86. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $155.35. The stock has a market capitalization of $40.58 billion, a P/E ratio of 32.88, a P/E/G ratio of 6.96 and a beta of 1.05.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the business posted $1.43 earnings per share. The firm’s quarterly revenue was down 5.6% compared to the same quarter last year. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st will be given a $0.236 dividend. The ex-dividend date is Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.68%. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the transaction, the chief executive officer now directly owns 26,076 shares in the company, valued at $3,650,640. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Friday, July 26th. The shares were sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the sale, the chief executive officer now owns 26,076 shares of the company’s stock, valued at $3,650,640. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,953 shares of company stock valued at $2,013,630. 0.33% of the stock is owned by corporate insiders.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.